Treating patients presenting with advanced glaucoma - Should we reconsider current practice?

British Journal of Ophthalmology

Volumn 95, Issue 9, 2011, Pages 1185-1192

  King, Anthony J ^a   Stead, Richard E ^a   Rotchford, Alan P ^b  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; FLUOROURACIL; GUANETHIDINE; MITOMYCIN C; PILOCARPINE; PLACEBO; TIMOLOL;

BLINDNESS; CATARACT; CATARACT EXTRACTION; CLINICAL PRACTICE; GLAUCOMA; GLAUCOMA SURGERY; HEALTH CARE COST; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; OPEN ANGLE GLAUCOMA; PATIENT COMPLIANCE; POSTOPERATIVE COMPLICATION; PRIMARY GLAUCOMA; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; SURGICAL RISK; TRABECULECTOMY; VISUAL ACUITY; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

ANTIHYPERTENSIVE AGENTS; BLINDNESS; DECISION MAKING; DISEASE PROGRESSION; FILTERING SURGERY; GLAUCOMA; GREAT BRITAIN; HUMANS; INCIDENCE; INTRAOCULAR PRESSURE; RISK FACTORS;

EID: 80052120595     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.188128     Document Type: Review

References (98)

1. National Institute for Health and Clinical Excellence (NICE). Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular Hypertension. Clinical guidelines CG85, UK National Institute for Health and Clinical Excellence (NICE) guidelines, April 2009.
2. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004;82:844-51. (Pubitemid 39573742)
3. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:262-7. (Pubitemid 43325451)
4. Mitchell P, Smith W, Attebo K, et al. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 1996;103:1661-9. (Pubitemid 26357144)
5. Wolfs RC, Borger PH, Ramrattan RS, et al. Changing views on open-angle glaucoma: definitions and prevalences - The Rotterdam Study. Invest Ophthalmol Vis Sci 2000;41:3309-21.
6. De Voogd S, Ikram MK, Wolfs RC, et al. Incidence of open-angle glaucoma in a general elderly population: the Rotterdam Study. Ophthalmology 2005;112:1487-93. (Pubitemid 41725401)
7. Bonomi L, Marchini G, Marraffa M, et al. Prevalence of glaucoma and intraocular pressure distribution in a defined population. The Egna-Neumarkt Study. Ophthalmology 1998;105:209-15. (Pubitemid 28090822)
8. Tielsch JM, Sommer A, Katz J, et al. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. Jama 1991;266:369-74.
9. Bunce C, Wormald R. Causes of blind certifications in England and Wales: April 1999 - March 2000. Eye 2008;22:905-11.
10. King AJ, Reddy A, Thompson JR, et al. The rates of blindness and of partial sight registration in glaucoma patients. Eye 2000;14(Pt 4):613-19.
11. Ng WS, Agarwal PK, Sidiki S, et al. The effect of socio-economic deprivation on severity of glaucoma at presentation. Br J Ophthalmol 2010;94:85-7.
12. Grant WM, Burke JF Jr. Why do some people go blind from glaucoma? Ophthalmology 1982;89:991-8. (Pubitemid 12001626)
13. Sheldrick JH, Ng C, Austin DJ, et al. An analysis of referral routes and diagnostic accuracy in cases of suspected glaucoma. Ophthalmic Epidemiol 1994;1:31-9.
14. Hattenhauer MG, Johnson DH, Ing HH, et al. The probability of blindness from open-angle glaucoma. Ophthalmology 1998;105:2099-104. (Pubitemid 30211780)
15. Elkington ARLJ, MacKean J, Sargent P. A collaborative hospital glaucoma survey. Res Clin Forums 1982;4:31-40.
16. Coffey M, Reidy A, Wormald R, et al. Prevalence of glaucoma in the west of Ireland. Br J Ophthalmol 1993;77:17-21. (Pubitemid 23031807)
17. Fraser S, Bunce C, Wormald R. Risk factors for late presentation in chronic glaucoma. Invest Ophthalmol Vis Sci 1999;40:2251-7. (Pubitemid 29418379)
18. Sukumar S, Spencer F, Fenerty C, et al. The influence of socioeconomic and clinical factors upon the presenting visual field status of patients with glaucoma. Eye (Lond) 2009;23:1038-44.
19. Odberg T. Visual field prognosis in advanced glaucoma. Acta Ophthalmol 1987;65(suppl):27-9. (Pubitemid 18028373)
20. Mikelberg FS, Schulzer M, Drance SM, et al. The rate of progression of scotomas in glaucoma. Am J Ophthalmol 1986;101:1-6. (Pubitemid 16128717)
21. Wilson R, Walker AM, Dueker DK, et al. Risk factors for rate of progression of glaucomatous visual field loss: a computer-based Analysis. Arch Ophthalmol 1982;100:737-41. (Pubitemid 12156585)
22. Parc CE, Johnson DH, Oliver JE, et al. The long-term outcome of glaucoma filtration surgery. Am J Ophthalmol 2001;132:27-35. (Pubitemid 32600886)
23. Oliver JE, Hattenhauer MG, Herman D, et al. Blindness and glaucoma: A comparison of patients progressing to blindness from glaucoma with patients maintaining vision. Am J Ophthalmol 2002;133:764-72. (Pubitemid 34580623)
24. Burr J, Azuara-Blanco A, Avenell A. Medical versus surgical interventions for open Angle glaucoma. Cochrane Database Syst Rev 2005;(2):CD004399.
25. Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001;108:1943-53.
26. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998;126:487-97.
27. Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:714-20; discussion 829-30.
28. Anon. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol 2000;130:429-40.
29. Carassa RG, Bettin P, Fiori M, et al. Viscocanalostomy versus trabeculectomy in white adults affected by open-angle glaucoma: a 2-year randomized, controlled trial. Ophthalmology 2003;110:882-7. (Pubitemid 36560483)
30. Chiselita D. Non-penetrating deep sclerectomy versus trabeculectomy in primary open-angle glaucoma surgery. Eye 2001;15(Pt 2):197-201. (Pubitemid 32377661)
31. Cillino S, Di Pace F, Casuccio A, et al. Deep sclerectomy versus trabeculectomy with low-dosage mitomycin C: four-year follow-up. Ophthalmologica 2008;222:81-7. (Pubitemid 351311708)
32. Gilmour DF, Manners TD, Devonport H, et al. Viscocanalostomy versus trabeculectomy for primary open angle glaucoma: 4-Year prospective randomized clinical trial. Eye 2009;23:1802-7.
33. Jonescu-Cuypers C, Jacobi P, Konen W, et al. Primary viscocanalostomy versus trabeculectomy in white patients with open-angle glaucoma: a randomized clinical trial. Ophthalmology 2001;108:254-8. (Pubitemid 32115952)
34. Kobayashi H, Kobayashi K, Okinami S. A comparison of the intraocular pressure-lowering effect and safety of viscocanalostomy and trabeculectomy with mitomycin C in bilateral open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 2003;241:359-66.
35. O'Brart DP, Rowlands E, Islam N, et al. A randomised, prospective study comparing trabeculectomy augmented with antimetabolites with a viscocanalostomy technique for the management of open angle glaucoma uncontrolled by medical therapy. Br J Ophthalmol 2002;86:748-54. (Pubitemid 34713160)
36. O'Brart DP, Shiew M, Edmunds B. A randomised, prospective study comparing trabeculectomy with viscocanalostomy with adjunctive antimetabolite usage for the management of open angle glaucoma uncontrolled by medical therapy. Br J Ophthalmol 2004;88:1012-17. (Pubitemid 39013141)
37. Migdal C, Gregory W, Hitchings R. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology 1994;101:1651-6; discussion 1657.
38. Jay JL, Murray SB. Early trabeculectomy versus conventional management in primary open Angle glaucoma. Br J Ophthalmol 1988;72:881-9. (Pubitemid 19022860)
39. Smith R. A comparison between medical and surgical treatment of glaucoma simplex - results of a prospective study. Trans Ophthalmol Soc Aust 1968;27:17-29.
40. Anon. The Advanced Glaucoma Intervention Study (AGIS): 1. Study design and methods and baseline characteristics of study patients. Control Clin Trials 1994;15:299-325.
41. Musch DC, Gillespie BW, Lichter PR, et al. Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors. Ophthalmology 2009;116:200-7.
42. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1998;126:498-505.
43. Bengtsson B, Leske MC, Hyman L, et al. Fluctuation of intraocular pressure and glaucoma progression in The early manifest glaucoma trial. Ophthalmology 2007;114:205-9. (Pubitemid 46161799)
44. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002;120:1268-79. (Pubitemid 36105431)
45. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003;121:48-56. (Pubitemid 36401765)
46. Leske MC, Heijl A, Hyman L, et al. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 2007;114:1965-72. (Pubitemid 350016362)
47. Chauhan BC, Mikelberg FS, Balaszi AG, et al. Canadian Glaucoma Study: 2. Risk factors for the progression of open-angle glaucoma. Arch Ophthalmol 2008;126:1030-6.
48. Jay JL. Earlier trabeculectomy. Trans Ophthalmol Soc UK 1983;103(Pt 1):35-8. (Pubitemid 14233789)
49. Jay JL, Allan D. The benefit of early trabeculectomy versus conventional management in primary open angle glaucoma relative to severity of disease. Eye 1989;3(Pt 5):528-35. (Pubitemid 20018423)
50. Konstas AG, Topouzis F, Leliopoulou O, et al. 24-Hour intraocular pressure control with maximum medical therapy compared with surgery in patients with advanced open-angle glaucoma. Ophthalmology 2006;113:761-5 e1.
51. Medeiros FA, Pinheiro A, Moura FC, et al. Intraocular pressure fluctuations in medical versus surgically treated glaucomatous patients. J Ocul Pharmacol Ther 2002;18:489-98. (Pubitemid 36020250)
52. Shaarawy T, Flammer J, Haefliger IO. Reducing intraocular pressure: Is surgery better than drugs? Eye (Lond) 2004;18:1215-24. (Pubitemid 40089992)
53. Asrani S, Zeimer R, Wilensky J, et al. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma 2000;9:134-42. (Pubitemid 32441322)
54. Jay JL. Rational choice of therapy in primary open And normalPressure openAngle glaucoma. Eye (Lond) 1992;6(Pt 3):243-7. (Pubitemid 23055161)
55. Stalmans I, Gillis A, Lafaut AS, et al. Safe trabeculectomy technique: Long term outcome. Br J Ophthalmol 2006;90:44-7. (Pubitemid 43029895)
56. Dhingra S, Khaw PT. The Moorfields safer surgery system. Middle East Afr J Ophthalmol 2009;16:112-15.
57. Jones E, Clarke J, Khaw PT. Recent advances in trabeculectomy technique. Curr Opin Ophthalmol 2005;16:107-13. (Pubitemid 43790803)
58. Wells AP, Bunce C, Khaw PT. Flap and suture manipulation after trabeculectomy with adjustable sutures: Titration of flow and intraocular pressure in guarded filtration surgery. J Glaucoma 2004;13:400-6. (Pubitemid 39281582)
59. Khaw PT, Wells AP, Lim KS. Surgery for glaucoma in the 21st century. Br J Ophthalmol 2002;86:710-11. (Pubitemid 34713150)
60. Khaw PT, Wells AP. Trabeculectomy in the UK: Is there room for improvement? Eye (Lond) 2001;15(Pt 4):437-8. (Pubitemid 32755709)
61. Edmunds B, Thompson JR, Salmon JF, et al. The National Survey of Trabeculectomy. III. Early and late complications. Eye (Lond) 2002;16:297-303. (Pubitemid 34618829)
62. Singh K, Mehta K, Shaikh NM, et al. Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial. Ophthalmology 2000;107:2305-9.
63. Wong TT, Khaw PT, Aung T, et al. The Singapore 5-fluorouracil trabeculectomy study: effects on intraocular pressure control and disease progression at 3 years. Ophthalmology 2009;116:175-84.
64. Hylton C, Congdon N, Friedman D, et al. Cataract after glaucoma filtration surgery. Am J Ophthalmol 2003;135:231-2. (Pubitemid 36151806)
65. Anon. The Advanced Glaucoma Intervention Study, 6: Effect of cataract on visual field and visual acuity. The AGIS Investigators. Arch Ophthalmol 2000;118:1639-52.
66. Herman DC, Gordon MO, Beiser JA, et al. Topical ocular hypotensive medication and lens opacification: Evidence from the ocular hypertension treatment study. Am J Ophthalmol 2006;142:800-10.
67. Rebolleda G, Munoz-Negrete FJ. Phacoemulsification in Eyes with functioning filtering blebs: a prospective study. Ophthalmology 2002;109:2248-55. (Pubitemid 35417106)
68. Casson R, Rahman R, Salmon JF. Phacoemulsification with intraocular lens implantation after trabeculectomy. J Glaucoma 2002;11:429-33.
69. Janz NK, Wren PA, Lichter PR, et al. The Collaborative Initial Glaucoma Treatment Study: Interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology 2001;108:1954-65. (Pubitemid 33032761)
70. Traverso CE, Walt JG, Kelly SP, et al. Direct costs of glaucoma and severity of the disease: A multinational long term study of resource utilisation in Europe. Br J Ophthalmol 2005;89:1245-9. (Pubitemid 41638858)
71. Ainsworth JR, Jay JL. Cost analysis of early trabeculectomy versus conventional management in primary open Angle glaucoma. Eye (Lond) 1991;5(Pt 3):322-8.
72. King AJ, Rotchford AP, Alwitry A, et al. Frequency of bleb manipulations after trabeculectomy surgery. Br J Ophthalmol 2007;91:873-7. (Pubitemid 47013093)
73. DiMatteo MR, Giordani PJ, Lepper HS, et al. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002;40:794-811.
74. Kass MA, Gordon M, Meltzer DW. Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy? Am J Ophthalmol 1986;101:524-30. (Pubitemid 16114196)
75. Lacey J, Cate H, Broadway DC. Barriers to adherence with glaucoma medications: A qualitative research study. Eye 2009;23:924-32.
76. Olthoff CM, Hoevenaars JG, Van den Borne BW, et al. Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients. Graefes Arch Clin Exp Ophthalmol 2009;247:235-43.
77. Olthoff CM, Schouten JS, Van de Borne BW, et al. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology 2005;112:953-61. (Pubitemid 40797446)
78. Quigley HA. Improving eye drop treatment for glaucoma through better adherence. Optom Vis Sci 2008;85:374-5.
79. Rotchford AP, Murphy KM. Compliance with timolol treatment in glaucoma. Eye 1998;12(Pt 2):234-6. (Pubitemid 28263862)
80. Tsai JC. Medication adherence in glaucoma: Approaches for optimizing patient compliance. Curr Opin Ophthalmol 2006;17:190-5. (Pubitemid 43790816)
81. Tsai JC, McClure CA, Ramos SE, et al. Compliance barriers in glaucoma: A systematic classification. J Glaucoma 2003;12:393-8. (Pubitemid 37237370)
82. Broadway D, Hitchings R. Conjunctival damage induced by long-term topical anti-glaucoma therapy. Acta Ophthalmol Scand 1996;74:97.
83. Broadway DC, Grierson I, O'Brien C, et al. Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol 1994;112:1446-54. (Pubitemid 24350507)
84. Broadway DC, Grierson I, Sturmer J, et al. Reversal of topical antiglaucoma medication effects on the conjunctiva. Arch Ophthalmol 1996;114:262-7. (Pubitemid 26086730)
85. Bron A. [Ocular hypertension and glaucoma: the contribution of large studies to daily practice]. J Fr Ophtalmol 2002;25:641-54.
86. Stead R, King AJ. Treatment Preferences of Consultant Ophthalmologists for Primary Management of Patients Presenting with Advanced Glaucoma. Liverpool: UK and Eire Glaucoma Society, 2009.
87. Hitchings RA. Primary surgery for primary open angle glaucoma - justified or not? Br J Ophthalmol 1993;77:445-8. (Pubitemid 23219825)
88. Bhargava JS, Patel B, Foss AJ, et al. Views of glaucoma patients on aspects of their treatment: An assessment of patient preference by conjoint analysis. Invest Ophthalmol Vis Sci 2006;47:2885-8. (Pubitemid 351639762)
89. Burr JM, Kilonzo M, Vale L, et al. Developing a preference-based Glaucoma Utility Index using a discrete choice experiment. Optom Vis Sci 2007;84:797-808. (Pubitemid 47262991)
90. Meads C, Hyde C. What is the cost of blindness? Br J Ophthalmol 2003;87:1201-4. (Pubitemid 37193905)
91. Frick KD, Gower EW, Kempen JH, et al. Economic impact of visual impairment and blindness in the United States. Arch Ophthalmol 2007;125:544-50. (Pubitemid 46596727)
92. Frick KD, Walt JG, Chiang TH, et al. Direct costs of blindness experienced by patients enrolled in managed care. Ophthalmology 2008;115:11-17. (Pubitemid 350309399)
93. Boger WP 3rd. Short-term "escape" and long-term "drift." The dissipation effects of the beta adrenergic blocking agents. Surv Ophthalmol 1983;28(Suppl):235-42.
94. Steinert RF, Thomas JV, Boger WP 3rd. Long-term drift and continued efficacy after multiyear timolol therapy. Arch Ophthalmol 1981;99:100-3. (Pubitemid 11168778)
95. Brubaker RF, Nagataki S, Bourne WM. Effect of chronically administered timolol on aqueous humor flow in patients with glaucoma. Ophthalmology 1982;89:280-3. (Pubitemid 12143091)
96. Chen TC, Wilensky JT, Viana MA. Long-term follow-up of initially successful trabeculectomy. Ophthalmology 1997;104:1120-5. (Pubitemid 27423854)
97. Wilensky JT, Chen TC. Long-term results of trabeculectomy in eyes that were initially successful. Trans Am Ophthalmol Soc 1996;94:147-59; discussion 160-4.
98. Suzuki R, Dickens CJ, Iwach AG, et al. Long-term follow-up of initially successful trabeculectomy with 5-fluorouracil injections. Ophthalmology 2002;109:1921-4.